Merging with Welcia and becoming an Aeon subsidiary (2024)

A thirty-year setup, and where the merger goes

What sets this integration apart is that Tsuruha was the driving party and, at the same time, became a subsidiary of Aeon. Even as it took Welcia in by share exchange to stand at the top with $13.4B (¥2tn) in sales, it accepted a tender offer and handed a majority of its own shares to Aeon. The summit of scale and the transfer of control happen on the front and back of the same deal. An alliance struck in 1995, as a regional chain tying up with national capital, swelled over thirty years into the core of an industry realignment — and while the founding family’s name stayed, the initiative in governance passed to Aeon. The merger with a peer that Oasis had pressed for came true, but by a route other than the one the activist had drawn.

Yet completing the merger on paper and making two organisations function as one are different things. How to bind together businesses with heavy overlap — purchasing, logistics, private brands, dispensing — and actually draw out the disclosed $334.1M (¥50bn) in synergies remains, as of this writing, an open task. Outstripping Matsumotokiyoshi and Cocokara Fine in sales does not guarantee the lead in earning power or store productivity. Whether a federated aggregate that began as a regional pharmacy can step into unified management under Aeon’s vast umbrella — the outcome of this Sapporo-born chain, ninety-six years in the making, rests on the integration work still to come.